Formulation and Product Development

At PharmaForm, pharmaceutical product development involves integrating numerous regulatory requirements with the complexities of the pharmaceutical sciences, process development and manufacturing. Our scientists approach each formulation project with the end product in mind. The Formulation and Product Development laboratory staff work closely with the Analytical Services team who provides dedicated analytical support to enhance completion of the project. Searching for creative solutions to pharmaceutical development challenges is a routine part of our work. The solutions we offer are tailored to your exact needs, with the primary objective of commercial success. Click here to download a list of our manufacturing equipment.

PharmaForm is registered with the DEA and is licensed to work with controlled substances. From early development through late-phase clinical trials, PharmaForm offers the entire range of integrated product development services you need, including formulation development laboratory space for client specific projects.

Dosage Form Development Capabilities:
  • Solids:
    • Tablets and Capsules

    • Hard and Soft Gelatin Capsules

    • Liquid-Filled Hard Gelatin and HPMC Capsules

    • Coating - film, spray, sustained release, controlled release

    • Oral Powders for Reconstitution

    • Wet and Dry Granulations

    • Hot Melt Extrusion


  • Transmucosal:
    • Films systems for delivery to the buccal mucosa


  • Topical and Semi-solids:
    • Ointments, Creams, Gels

    • Solutions, Suspensions, Syrups

    • Liquids - improved solubility and taste masking


  • Nasal and Pulmonary Delivery:
    • Pressurized Metered Dose Inhalers

    • Nasal Sprays - Aqueous pumps


  • Targeted Delivery:

    • Immediate Release

    • Sustained / Controlled Release

    • Enteric Release

The development of computational chemistry and high throughput screening has resulted in a multitude of NCEs capable of treating a variety of disease states. However, many of these compounds have shown a substantial decrease in dissolution rate and bioavailability. Increasing the bioavailability of poorly soluble drug compounds is one of the greatest challenges facing the pharmaceutical industry today. PharmaForm offers a variety of bioavailability enhancement technologies for overcoming these challenges, enabling companies to capitalize on the full potential of their highly effective yet poorly soluble compounds. Technologies include: